These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 17640917

  • 1. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.
    Lu J, Chew EH, Holmgren A.
    Proc Natl Acad Sci U S A; 2007 Jul 24; 104(30):12288-93. PubMed ID: 17640917
    [Abstract] [Full Text] [Related]

  • 2. The thioredoxin antioxidant system.
    Lu J, Holmgren A.
    Free Radic Biol Med; 2014 Jan 24; 66():75-87. PubMed ID: 23899494
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J, Papp LV, Fang J, Rodriguez-Nieto S, Zhivotovsky B, Holmgren A.
    Cancer Res; 2006 Apr 15; 66(8):4410-8. PubMed ID: 16618767
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S, Zhang J, Li J, Chen D, Matteucci M, Curd J, Duan JX.
    Biol Trace Elem Res; 2010 Sep 15; 136(3):294-301. PubMed ID: 19838642
    [Abstract] [Full Text] [Related]

  • 5. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
    Zhang H, Cao D, Cui W, Ji M, Qian X, Zhong L.
    Free Radic Biol Med; 2010 Dec 15; 49(12):2010-8. PubMed ID: 20951799
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
    Fang J, Holmgren A.
    J Am Chem Soc; 2006 Feb 15; 128(6):1879-85. PubMed ID: 16464088
    [Abstract] [Full Text] [Related]

  • 7. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
    Davioud-Charvet E, McLeish MJ, Veine DM, Giegel D, Arscott LD, Andricopulo AD, Becker K, Müller S, Schirmer RH, Williams CH, Kenyon GL.
    Biochemistry; 2003 Nov 18; 42(45):13319-30. PubMed ID: 14609342
    [Abstract] [Full Text] [Related]

  • 8. Targeting the Thioredoxin System for Cancer Therapy.
    Zhang J, Li X, Han X, Liu R, Fang J.
    Trends Pharmacol Sci; 2017 Sep 18; 38(9):794-808. PubMed ID: 28648527
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione.
    Lu J, Vlamis-Gardikas A, Kandasamy K, Zhao R, Gustafsson TN, Engstrand L, Hoffner S, Engman L, Holmgren A.
    FASEB J; 2013 Apr 18; 27(4):1394-403. PubMed ID: 23248236
    [Abstract] [Full Text] [Related]

  • 10. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant.
    Zhao R, Masayasu H, Holmgren A.
    Proc Natl Acad Sci U S A; 2002 Jun 25; 99(13):8579-84. PubMed ID: 12070343
    [Abstract] [Full Text] [Related]

  • 11. Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity.
    Chew EH, Lu J, Bradshaw TD, Holmgren A.
    FASEB J; 2008 Jun 25; 22(6):2072-83. PubMed ID: 18180330
    [Abstract] [Full Text] [Related]

  • 12. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
    Tonissen KF, Di Trapani G.
    Mol Nutr Food Res; 2009 Jan 25; 53(1):87-103. PubMed ID: 18979503
    [Abstract] [Full Text] [Related]

  • 13. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V, Fernandes AP, Rigobello MP, Dani B, Sorrentino F, Tisato F, Björnstedt M, Bindoli A, Sturaro A, Rella R, Marzano C.
    Biochem Pharmacol; 2010 Jan 15; 79(2):90-101. PubMed ID: 19665452
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
    Liu Z, Huang SL, Li MM, Huang ZS, Lee KS, Gu LQ.
    Chem Biol Interact; 2009 Jan 15; 177(1):48-57. PubMed ID: 18822278
    [Abstract] [Full Text] [Related]

  • 15. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
    You BR, Park WH.
    Oncol Rep; 2012 Aug 15; 28(2):749-57. PubMed ID: 22684917
    [Abstract] [Full Text] [Related]

  • 16. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
    Wang X, Zhang J, Xu T.
    Toxicol Appl Pharmacol; 2007 Jan 01; 218(1):88-95. PubMed ID: 17156807
    [Abstract] [Full Text] [Related]

  • 17. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
    Zheng CY, Lam SK, Li YY, Ho JC.
    Int J Oncol; 2015 Mar 01; 46(3):1067-78. PubMed ID: 25572414
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex.
    Arnér ES, Nakamura H, Sasada T, Yodoi J, Holmgren A, Spyrou G.
    Free Radic Biol Med; 2001 Nov 15; 31(10):1170-8. PubMed ID: 11705695
    [Abstract] [Full Text] [Related]

  • 19. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
    Montano SJ, Lu J, Gustafsson TN, Holmgren A.
    Anal Biochem; 2014 Mar 15; 449():139-46. PubMed ID: 24374250
    [Abstract] [Full Text] [Related]

  • 20. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
    Huang J, Xu J, Tian L, Zhong L.
    Biochimie; 2014 Feb 15; 97():92-103. PubMed ID: 24103200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.